drugset / Trial / NCT06801223
A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to investigate the use of Sulbactam-Durlobactam (SUL-DUR) in pediatric patients and is being conducted to collect pharmacokinetic (PK) and safety data to enable the identification of appropriate pediatric dosing regimens for patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections
Timeline
- Start
- 2026-10-30
- Primary completion
- 2028-05-05
- Completion
- 2028-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Durlobactam | Small molecule | 20 mg/kg | — |
| Subject | Durlobactam | Small molecule | 25 mg/kg | — |
| Subject | Sulbactam | Small molecule | 20 mg/kg | — |
| Subject | Sulbactam | Small molecule | 25 mg/kg | — |